(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-04-11 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 1161210
| Date | Daily Closing Price | Open | High | Low | Volume |
| 11 Thu Apr 2024 | 1.29 | 1.28 | 1.34 | 1.26 | 0.76 times |
| 10 Wed Apr 2024 | 1.27 | 1.33 | 1.33 | 1.25 | 1.305 times |
| 09 Tue Apr 2024 | 1.37 | 1.36 | 1.41 | 1.35 | 0.618 times |
| 08 Mon Apr 2024 | 1.36 | 1.40 | 1.41 | 1.33 | 0.883 times |
| 05 Fri Apr 2024 | 1.37 | 1.39 | 1.42 | 1.32 | 1.038 times |
| 04 Thu Apr 2024 | 1.35 | 1.41 | 1.45 | 1.35 | 0.669 times |
| 03 Wed Apr 2024 | 1.38 | 1.40 | 1.42 | 1.35 | 1.409 times |
| 02 Tue Apr 2024 | 1.40 | 1.46 | 1.46 | 1.36 | 0.989 times |
| 01 Mon Apr 2024 | 1.47 | 1.55 | 1.55 | 1.45 | 1.149 times |
| 28 Thu Mar 2024 | 1.58 | 1.65 | 1.65 | 1.53 | 0.92 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 1.3, but if it comes above 1.3, then a intra day buy could be more profitable.
If you take a sell trade below 1.3, then use 1.3 as stoploss and 1.2 as target. However if you take a buy trade in stock , then use 1.3 as stoploss and 1.42 as target.
Share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Target | 0.43 |
| Downside Target | 0.65 |
| Downside Target | 0.84 |
| Downside Target | 0.92 |
| Downside Target | 1.04 |
| Downside Target | 1.24 |
| Upside Target | 1.32 |
| Upside Target | 1.38 |
| Upside Target | 1.41 |
| Upside Target | 1.52 |
| Upside Target | 1.55 |
| Upside Target | 1.65 |
| Upside Target | 1.79 |
| Upside Target | 1.80 |
| Upside Target | 2.05 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Intraday Target | 1.22 |
| Downside Intraday Target | 1.16 |
| Upside Intraday Target | 1.38 |
| Upside Intraday Target | 1.48 |
| Upside Intraday Target | 1.32 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 11 Thu Apr 2024 | 1.29 | 1.40 | 1.41 | 1.25 | 0.679 times |
| 05 Fri Apr 2024 | 1.37 | 1.55 | 1.55 | 1.32 | 1.32 times |
| 28 Thu Mar 2024 | 1.58 | 1.46 | 1.65 | 1.38 | 0.566 times |
| 22 Fri Mar 2024 | 1.44 | 1.50 | 1.52 | 1.24 | 1.152 times |
| 15 Fri Mar 2024 | 1.48 | 1.80 | 1.80 | 1.41 | 0.379 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 11 Thu Apr 2024 | 1.29 | 1.55 | 1.55 | 1.25 | 0.259 times |
| 28 Thu Mar 2024 | 1.58 | 1.56 | 2.05 | 1.24 | 1.055 times |
| 29 Thu Feb 2024 | 1.57 | 1.03 | 1.79 | 0.92 | 0.965 times |
| 31 Wed Jan 2024 | 0.96 | 0.81 | 1.04 | 0.65 | 2.174 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Adaptimmune Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.38 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Adaptimmune Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.38 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.